CymaBay Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
CymaBay Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2023.
  • CymaBay Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2023 was $596K.
  • CymaBay Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2023 was -$3.69M, a 71.4% increase year-over-year.
  • CymaBay Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$3.69M, a 71.4% increase from 2022.
  • CymaBay Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$12.9M, a 434% decline from 2021.
  • CymaBay Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$2.42M, a 250% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3.69M +$9.2M +71.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$12.9M -$10.5M -434% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$2.42M -$4.03M -250% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $1.62M -$3.73M -69.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 $5.34M +$5.39M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 -$43K +$6.19M +99.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 -$6.23M -$5.15M -474% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-28
2016 -$1.09M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.